BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

The U.S. Army seeks prototype agreements (OTAs) to develop medical CBRN countermeasures and enabling biotechnologies under a Broad Agency Announcement (BAA). Offerors must submit a full proposal that includes a 20‑page Technical Section (acronyms, project objective, background, and a detailed technical approach demonstrating acceptable risk) and a 20‑page Project Management Section (stand‑alone Statement of Work following MIL‑HDBK‑245D, CWBS and dictionary, risk‑management plan, and management approach). Required contact information for both technical and administrative points of contact must be provided, along with the proposal submission date. Proposals will be evaluated on technical merit, safety/efficacy data, compliance with GLP/cGMP/GCP, and overall risk, by a multidisciplinary panel. Pricing may be firm‑fixed‑price or cost‑reimbursement; cost proposals must follow the template attached to the specific RPP or be submitted in a read‑only Excel file for cost‑reimbursement offers. The technology must generally be at TRL 4 or higher, address an identified need, and reduce programmatic risk. Preproposals (max 11 pages) describing a specific idea, supporting data, high‑level WBS, qualifications, IP restrictions, and anticipated cost may be submitted at any time to usarmy.detrick.mcs.mbx.baa@mail.mil. Brochures or generic capability statements are not acceptable. All submissions must include the required contact details, and the Government will acknowledge receipt and assign a tracking number. Successful proposals will incorporate the final SOW into the contract and must include a comprehensive risk‑management plan and clear, logical project objectives.

Notice ID

0056d5583f194e4b87e604517c01da5b

Solicitation Number

CBRND-BAA-22-01

NAICS Code

541715

Classification Code

AC12